Package Leaflet: Information for the User
Progit 50mg film-coated tablets EFG
Itopride hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the package leaflet
Progit 50 mg belongs to a group of medicines called prokinetic agents. Prokinetic agents are medicines that normalize or improve and accelerate intestinal movement (motility).
This medicine is indicated for the treatment of symptoms derived from slow gastric emptying, such as a feeling of gastric fullness or pain in the upper abdominal area, lack of appetite, heartburn, nausea, and vomiting, which are not caused by an ulcerative disease or an organic disease that affects the speed of passage of digested food through the gastrointestinal tract.
This medicine is intended for adults.
Do not take Progit 50mg
Warnings and precautions
Consult your doctor or pharmacist before taking this medicine.
Itopride hydrochloride enhances the action of acetylcholine and caution should be exercised when administering this medicine.
In case of adverse effects in elderly patients, the doctor will take appropriate measures, such as reducing the dose or interrupting treatment.
Other medicines and Progit 50mg
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
No interactions have been observed with the co-administration of warfarin, diazepam, diclofenac, ticlopidine, nifedipine, and nicardipine.
Since this medicine has gastrokinetic effects, it may influence the absorption of drugs administered simultaneously by mouth.
Anticholinergics (used to treat asthma, chronic obstructive pulmonary disease, diarrhea, support anesthesia, Parkinson's disease, and to reduce muscle spasms – e.g., the urinary bladder or the gastrointestinal tract) may decrease the effect of itopride.
Anti-ulcer drugs (used to prevent and treat ulcers in the digestive tract), such as cimetidine, ranitidine, teprenone, and cetrexate, do not affect the effect of this medicine on gastrointestinal motility.
Itopride may influence the absorption of other medicines due to its effect on the digestive tract, particularly medicines with a narrow therapeutic index, sustained-release medicines, and those released in the intestine.
Progit 50mg with food and drinks
This medicine should be taken before meals.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
In pregnant or breastfeeding women, or in those who cannot rule out pregnancy, this medicine should only be used if the therapeutic benefits clearly outweigh the potential risks.
Due to the potential risk of side effects in breastfed infants, the doctor will decide whether to suspend breastfeeding or interrupt treatment.
Driving and using machines
Although no influence of this medicine on the ability to drive and use machines has been observed, it cannot be ruled out that it may alter the state of alertness. In very rare cases, dizziness may occur. In these cases, do not drive or use machines until these symptoms disappear.
Progit 50mg contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Progit 50mg contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially 'sodium-free'.
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, ask your doctor or pharmacist.
The recommended daily dose for adults is 1 tablet three times a day before a meal.
Your doctor may reduce this dose depending on your age and the symptoms of the disease.
The duration of treatment will be determined by your doctor. This medicine should not be used for more than 8 weeks.
Use in children and adolescents
This medicine should not be administered to children and adolescents under 16 years of age.
If you take more Progit 50mg than you should
If you take more itopride than you should, or in case of accidental ingestion by a child, consult a doctor.
If you forget to take Progit 50mg
If you forget to take this medicine, continue with your usual dose schedule. Do not take a double dose to make up for forgotten doses.
If you stop taking Progit 50mg
If you stop taking this medicine before time, your symptoms may worsen. Consult your doctor before stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking this medicine and inform your doctor:
During treatment with this medicine, the following side effects may occur:
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from the available data)
If galactorrhea (production and secretion of breast milk not associated with breastfeeding) or gynecomastia (enlargement of the breasts in men) occurs, treatment should be interrupted or discontinued.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Surveillance System for Human Use:
www.notificaRAM.es
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton and blister after 'EXP'. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Progit 50mg
Appearance of the product and pack contents
Progit 50 mg are film-coated tablets, white or almost white, round, biconvex, scored, 7 mm in diameter.
The score line is only to facilitate breaking the tablet if you have difficulty swallowing it whole.
This medicine is available in blister packs of 15, 20, 30, 40, 60, 90, 100, or 120 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Kappler Pharma Consult GmbH,
Fonyoder Strasse 18,
89340 Leipheim, Bavaria
Germany
Manufacturer
Pro.Med.Cs Praha A.S.,
Telcská 377/1,
140 00 Michle, Prague,
Czech Republic
This medicine is authorized in the Member States of the European Economic Area under the following names:
Czech Republic Itopride Kappler
Estonia Itoprom
Latvia Progit 50 mg apvalkotas tabletes
Spain Progit 50 mg film-coated tablets EFG
Portugal Itomed
Italy Progit
Denmark Progit
Bulgaria Progit 50 mg ????????? ????????
Finland Progit 50 mg kalvopäällysteiset tabletit
Date of last revision of this leaflet:December 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.